- Home
- HKIT vs ITRM Comparison
HKIT vs ITRM Comparison
Compare HKIT & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- ITRM
- Stock Information
- Founded
- HKIT 1996
- ITRM 2015
- Country
- HKIT China
- ITRM Ireland
- Employees
- HKIT N/A
- ITRM N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- ITRM Health Care
- Exchange
- HKIT Nasdaq
- ITRM Nasdaq
- Market Cap
- HKIT 39.8M
- ITRM 40.0M
- IPO Year
- HKIT 2023
- ITRM 2018
- Fundamental
- Price
- HKIT $1.53
- ITRM $0.62
- Analyst Decision
- HKIT
- ITRM Strong Buy
- Analyst Count
- HKIT 0
- ITRM 2
- Target Price
- HKIT N/A
- ITRM $7.00
- AVG Volume (30 Days)
- HKIT 13.0K
- ITRM 917.9K
- Earning Date
- HKIT 10-27-2025
- ITRM 08-05-2025
- Dividend Yield
- HKIT N/A
- ITRM N/A
- EPS Growth
- HKIT N/A
- ITRM N/A
- EPS
- HKIT N/A
- ITRM N/A
- Revenue
- HKIT $2,904,950.00
- ITRM N/A
- Revenue This Year
- HKIT N/A
- ITRM N/A
- Revenue Next Year
- HKIT N/A
- ITRM $249.35
- P/E Ratio
- HKIT N/A
- ITRM N/A
- Revenue Growth
- HKIT N/A
- ITRM N/A
- 52 Week Low
- HKIT $1.15
- ITRM $0.63
- 52 Week High
- HKIT $1.79
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- HKIT 48.78
- ITRM 32.05
- Support Level
- HKIT $1.48
- ITRM $0.68
- Resistance Level
- HKIT $1.54
- ITRM $0.75
- Average True Range (ATR)
- HKIT 0.03
- ITRM 0.06
- MACD
- HKIT -0.01
- ITRM -0.01
- Stochastic Oscillator
- HKIT 9.90
- ITRM 2.52
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.